Roche is teaming up with Jiangsu, China-based Qyuns Therapeutics for a bispecific antibody that could potentially treat asthma, COPD and other respiratory diseases.
To start …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.